Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hartmann

Showing results (591-600 of 626) with videos related to

Pageof 63
Sort By:
The New England Journal of Medicine|July 22, 2005
Benign breast disease and the risk of breast cancerLynn C Hartmann, Thomas A Sellers, Marlene H Frost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2018
Model for Predicting Breast Cancer Risk in Women With Atypical HyperplasiaAmy C Degnim, Stacey J Winham, Ryan D Frank, et al.
Cancer Research|November 16, 2014
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancerEvanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.
Cancer|October 30, 2015
Clinicopathologic features of breast cancers that develop in women with previous benign breast diseaseDaniel W Visscher, Marlene H Frost, Lynn C Hartmann, et al.
Cancer Research|August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumorsV Shridhar, J Lee, A Pandita, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancerGottfried E Konecny, Boris Winterhoff, Teodora Kolarova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancerJanos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Cancer|June 29, 2016
Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of womenAmy C Degnim, William D Dupont, Derek C Radisky, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|February 18, 2010
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancerKristin L White, Thomas A Sellers, Brooke L Fridley, et al.
Pageof 63

Showing results (591-600 of 626) with videos related to

Sort By:
Pageof 63
The New England Journal of Medicine|July 22, 2005
Benign breast disease and the risk of breast cancerLynn C Hartmann, Thomas A Sellers, Marlene H Frost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2018
Model for Predicting Breast Cancer Risk in Women With Atypical HyperplasiaAmy C Degnim, Stacey J Winham, Ryan D Frank, et al.
Cancer Research|November 16, 2014
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancerEvanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.
Cancer|October 30, 2015
Clinicopathologic features of breast cancers that develop in women with previous benign breast diseaseDaniel W Visscher, Marlene H Frost, Lynn C Hartmann, et al.
Cancer Research|August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumorsV Shridhar, J Lee, A Pandita, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancerGottfried E Konecny, Boris Winterhoff, Teodora Kolarova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancerJanos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Cancer|June 29, 2016
Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of womenAmy C Degnim, William D Dupont, Derek C Radisky, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|February 18, 2010
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancerKristin L White, Thomas A Sellers, Brooke L Fridley, et al.
Pageof 63